Avicanna Inc.

AVICANNA CLOSES NON-BROKERED PRIVATE PLACEMENT RAISING $2.7 MILLION.

AVICANNA REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Avicanna and Red White & Bloom enter Exclusive Partnership for the Distribution and Commercialization of Pura H&W Hemp-Derived CBD-Based Topical Products in the United States

Avicanna Announces Participation in a Medical Cannabis Real-World Evidence (MC-RWE) Research Study Led by the University Health Network in Partnership with Medical Cannabis by Shoppers using its Rho Phyto Advanced Medical Cannabis Formulary of Products

Avicanna to Host Virtual Symposium Titled ‘Medical Cannabis 2.0’ on July 21st, 2020 in Partnership with Medical Cannabis By Shoppers(TM) in Anticipation of the Launch of its Rho Phyto(TM) Product Line

Avicanna Announces Co-development of a Cannabinoid-based Formulation for Treatment of COVID-19 related Lung Inflammation with Support from the Mitacs Accelerate Program

Avicanna Completes First Ever Export of Feminized Hemp Seeds For Cultivation Use to the United States and Closes the Initial Sale

Avicanna Successfully Registers the First Group of its Pura EarthTM CBD-Based Derma-Cosmetic Product Line in the European Union in Preparation for its Commercialization

AVICANNA REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

AVICANNA TO POSTPONE REPORTING FIRST QUARTER 2020 RESULTS DUE TO DELAYS CAUSED BY COVID-19

Avicanna Signs Wide-Ranging Strategic Manufacturing and IP Licensing Agreement with World-Class Canadian Manufacturer MediPharm Labs

AVICANNA RECEIVES GOVERNMENT SUPPORT AND APPROVAL FOR FIRST EVER EXPORT OF HEMP SEEDS FROM COLOMBIA

AVICANNA CLOSES NON-BROKERED PRIVATE PLACEMENT WITH GROUP OF STRATEGIC INVESTORS AND ANNOUNCES WARRANT RE-PRICING

AVICANNA REPORTS FOURTH QUARTER 2019 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

AVICANNA TO POSTPONE REPORTING FOURTH QUARTER AND FULL YEAR 2019 RESULTS DUE TO DELAYS CAUSED BY COVID-19

Avicanna Inc.: Avicanna to Supply Australian Market with Cannabis-Based Medicinal Products Through Distribution Agreement with Cannvalate

Avicanna Closes First Tranche of Private Placement

Avicanna Announces Appointment of Benjamin Leavenworth as Independent Director

Avicanna Announces Agreement with Medical Cannabis by Shoppers, a subsidiary of Shoppers Drug Mart Inc., to Distribute Avicanna’s Advanced and Evidence-based Medical Cannabis and Derma-Cosmetic Products Across Canada

Avicanna Inc. Enters Into USD$5 Million Revolving Credit Facility

Avicanna Inc.: Avicanna to Host Key Opinion Leader Meeting on the Use of Cannabinoids for the Treatment of Pain and Epilepsy

Avicanna Receives DTC Eligibility for Common Shares on OTCQX

Avicanna Announces Option to Purchase Newly Formed US Cannabis Operator

Avicanna to Supply UK Market with Cannabis-Based Medicinal Products Through Distribution Agreement with the LYPHE Group